Clinical Trial Update: Optimising TREATment for Severe Gram-Negative Bacterial Infections [Phase 4]

View source ↗

Summary

Phase 4 study focused on optimizing treatment for severe gram-negative infections; the trial is currently recruiting. It encompasses bloodstream infection, vent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bloodstream Infection
• Carbapenem-resistant Bacterial Infection
• Hospital-acquired Pneumonia
• Multidrug-resistant Bacterial Infection
• Ventilator-associated Pneumonia

Snippet

Sponsor: National University of Singapore | Conditions: Bloodstream Infection, Ventilator Associated Bacterial Pneumonia | Phase 4 | Status: RECRUITING